Owners will have to transport their dogs to their respective centres and pay the cost of the initial consultation for diagnosis. Once the pet is diagnosed with lymphoma, PharmAust will cover all clinical trial costs, including travel expenses to and from the trial centre as well as post-trial maintenance treatment if both pet owners and vets consider this might be beneficial.
The MPL tablets will be administered at home, and owners will be asked to keep a simple logbook during the trial period.
Pet owners interested in enrolling their dogs in the MPL trial need to contact their veterinarian for a referral to their nearest trial centre.
Veterinarians – for questions about patient referrals or trial sites, please get in touch with Principal Investigator, Dr Kim Agnew at kim@kapconsulting.com.au
For questions about the MPL trial program, please get in touch with Dr Roger Aston, Executive Chairman, PharmAust Ltd rogeraston@pharmaust.com
